What is Fondaparinux?

Category: Prescription Drugs

Most popular types: Arixtra


Fondaparinux is a Factor Xa Inhibitor that is used to prevent deep vein thrombosis (DVT) in patients undergoing hip replacement, knee replacement, hip fracture, or abdominal surgery; treatment of acute pulmonary embolism (PE).

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Prevent blood clotting 8 5
Deep vein thrombosis 3 1
Antiphospholipid antibody syndrome 2 1
Factor V Leiden 1 2
Pulmonary embolism 1 0
Raised homocysteine levels 1 0

Show all 7 reasons taken

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 0
Mild 3
None 5

Commonly reported side effects and conditions associated with Fondaparinux

Side effect Patients Percentage
Weight loss 1

Why patients stopped taking Fondaparinux

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 2
Course of treatment ended 1
Other 1
See all 3 patients who've stopped taking Fondaparinux


Stopped taking Fondaparinux

Duration Patients Percentage
Less than 1 month 1
1 - 6 months 2
Adherence Evaluations Percentage
Always 6
Usually 1
Sometimes 1
Never taken as prescribed 0
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 3
A little hard to take 2
Not at all hard to take 3
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 0
$25-49 1
< $25 0
Not specified 7

What people switch to and from

Patients started taking Fondaparinux after stopping:

Treatment Patients Percentage
Warfarin (Coumadin) 3
Enoxaparin (Lovenox) 1
Heparin 1
Rivaroxaban (Xarelto) 1

Patients stopped taking Fondaparinux and switched to:

Treatment Patients Percentage
Rivaroxaban (Xarelto) 1
Last updated:
There are no evaluations for Fondaparinux.